1. Home
  2. ASTE vs ABUS Comparison

ASTE vs ABUS Comparison

Compare ASTE & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTE
  • ABUS
  • Stock Information
  • Founded
  • ASTE 1972
  • ABUS N/A
  • Country
  • ASTE United States
  • ABUS United States
  • Employees
  • ASTE N/A
  • ABUS N/A
  • Industry
  • ASTE Construction/Ag Equipment/Trucks
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTE Industrials
  • ABUS Health Care
  • Exchange
  • ASTE Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • ASTE 848.7M
  • ABUS 725.9M
  • IPO Year
  • ASTE N/A
  • ABUS N/A
  • Fundamental
  • Price
  • ASTE $38.25
  • ABUS $3.51
  • Analyst Decision
  • ASTE Hold
  • ABUS Strong Buy
  • Analyst Count
  • ASTE 2
  • ABUS 4
  • Target Price
  • ASTE $38.50
  • ABUS $5.50
  • AVG Volume (30 Days)
  • ASTE 153.8K
  • ABUS 864.7K
  • Earning Date
  • ASTE 11-06-2024
  • ABUS 11-06-2024
  • Dividend Yield
  • ASTE 1.36%
  • ABUS N/A
  • EPS Growth
  • ASTE N/A
  • ABUS N/A
  • EPS
  • ASTE N/A
  • ABUS N/A
  • Revenue
  • ASTE $1,283,300,000.00
  • ABUS $6,742,000.00
  • Revenue This Year
  • ASTE $0.66
  • ABUS N/A
  • Revenue Next Year
  • ASTE $4.01
  • ABUS N/A
  • P/E Ratio
  • ASTE N/A
  • ABUS N/A
  • Revenue Growth
  • ASTE N/A
  • ABUS N/A
  • 52 Week Low
  • ASTE $28.46
  • ABUS $1.79
  • 52 Week High
  • ASTE $44.74
  • ABUS $4.72
  • Technical
  • Relative Strength Index (RSI)
  • ASTE 66.64
  • ABUS 34.90
  • Support Level
  • ASTE $35.40
  • ABUS $3.42
  • Resistance Level
  • ASTE $38.89
  • ABUS $3.56
  • Average True Range (ATR)
  • ASTE 1.33
  • ABUS 0.16
  • MACD
  • ASTE 0.01
  • ABUS -0.03
  • Stochastic Oscillator
  • ASTE 87.48
  • ABUS 16.67

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Share on Social Networks: